Serious riskFDA DrugClass II

Fresenius Kabi sodium chloride injection recalled for sterility concerns

Fresenius Kabi USA is recalling specific batches of 0.9% Sodium Chloride Injection (saline) because the manufacturer cannot confirm the product is sterile. Sterility is critical for injectable medications. The affected batches have expiration dates of October 31, 2026, or November 30, 2026.

From the FDA notice · Read the official notice ↗ · All Fresenius Kabi recalls

What to do

  1. Check your saline injection bottles for batch numbers 6402428, 6402481, or 6402482 and the expiration dates listed above.
  2. Do not use affected bottles. Contact your healthcare provider or pharmacy for replacement.
  3. If you have already used saline from these batches, inform your healthcare provider.

Is yours affected?

Compare your label or packaging with the recalled product.

Product
0.9% Sodium Chloride Injection, USP, 50 mL x60, Becton, Dickson and Company, 1 Beckton Drive, Franklin Lakes, NJ 07417 USA, Distributed by BD, Manufactured by Fresenius Kabi USA, LLC ("Fresenius Kabi"), Unit of Sale NDC Number: 17271-701-02.
Sold in
Nationwide
Made for
All ages (0 months and older)

This recall covers 14 products — see all of them.

Details

Illnesses reported
None reported
Manufactured in
3 Corporate Dr, Lake Zurich, IL, United States
Classification
Class II
Recall number
D-0429-2026

In the FDA's words

Description
0.9% Sodium Chloride Injection, USP, 50 mL x60, Becton, Dickson and Company, 1 Beckton Drive, Franklin Lakes, NJ 07417 USA, Distributed by BD, Manufactured by Fresenius Kabi USA, LLC ("Fresenius Kabi"), Unit of Sale NDC Number: 17271-701-02. Lack of Assurance of Sterility Batch# 6402428, Exp Date: 10/31/2026; Batch# 6402481, 6402482, Exp Date: 11/30/2026. Distribution: US Nationwide , Alaska, and Puerto Rico.
Hazard
Lack of Assurance of Sterility

14 products in this recall

Fresenius Kabi IV saline and dextrose bags recalled over sterility

Fresenius Kabi is recalling 14 sodium chloride and dextrose IV fluid bags because the company cannot assure they are sterile. The products were sold under the Fresenius Kabi, BD and Fresenius Medical Care names and were distributed nationwide, to Alaska and to Puerto Rico. No injuries have been reported.

The agency lists each product separately. Check every one you might have.

More from Fresenius Kabi

See all

Related topics

SterilityDrugsSold nationwideMore from FDA Drug